Antigen Mkdu Ppds 2016

Embed Size (px)

Citation preview

  • 8/19/2019 Antigen Mkdu Ppds 2016

    1/32

  • 8/19/2019 Antigen Mkdu Ppds 2016

    2/32

    microbe

    antigen

    epitope

    phagocyte

    Ag-binding site

    Fab region

    Fc region

    Fc receptor 

    Antibody (Ab)

    (Male, Brostoff, Roth, Roitt, 2006)

    (Yoes Prijatna Dachlan, 2011)

  • 8/19/2019 Antigen Mkdu Ppds 2016

    3/32

    acterial Pathogen

      S. pneumoniae

    !1"

    collagen

    region

    !1r !1s

    (Yoes Prijatna Dachlan, 201#)

  • 8/19/2019 Antigen Mkdu Ppds 2016

    4/32

    Ag can bind in pockets orgrooves or on extended

    surfaces in the binding sites ofAbs

    (Yoes Prijatna Dachlan, 2010)(Janeway, CA., 2001)(Janeway, CA., 2001)

  • 8/19/2019 Antigen Mkdu Ppds 2016

    5/32

    S. pneumoniae

    $psoni%ation$psoni%ation!&b

    !'$ !D

    !1" !'P AP

    PhagocytosisPhagocytosis

    'eceptor *or 

    !'P AP

    !&b'Fcϒ '

    S. pneumoniae

    (Yoes Prijatna a!hlan, 201")

  • 8/19/2019 Antigen Mkdu Ppds 2016

    6/32

    Ag 1

    Ag 2

    Ag &

     Ab 1

     Ab 2

     Ab &

     re+ognisi

     epitope

    A$D. '.!$/. .P$P.

    (Yoes Prijatna Dachlan, 2011)(Male, Brostoff, Roth, Roitt, 2006)

  • 8/19/2019 Antigen Mkdu Ppds 2016

    7/32

    Ag

    cell

    Plasma cellAgAb

    Actiation

    Ag

    (Yoes Prijatna Dachlan 2011)

    mmnogenicity, peci*icity

      3

    !lonal selection theory

    cell cell

    $. !.44 5 $. P.!F!Y

  • 8/19/2019 Antigen Mkdu Ppds 2016

    8/32

    #he Clonal $ele!tion

    #heory

    %n &enerati'e

    lyhoi* or&ans

    4ymphocyte clones matres

    in the absence o* Ags

    !lones o* matre

    lymphocytes

    speci*ic *or dierse Ags

     A&s enter

    lyhoi* tiss+es

    Ag-speci*ic clones are

      actiated (selected)

      by Ags

    Ag-speci*ic immne

      responses occr

    (Abbas, 2015)(Yoes Prijatna Dachlan,2015)

  • 8/19/2019 Antigen Mkdu Ppds 2016

    9/32

    Ag cell

    Ag

    'eceptor 

    AP!

    Antigen

    67!

    molecle!'

    cell

    A/. 

    - Mole!+les that are

     se!ifi!ally re!o&nie* /y

     anti&en re!etors either B

     !ells or # !ells

    - Mole!+les that initiate

     a*ati'e i+ne

     resonses

    (Yoes Prijatna Dachlan, 2011) (Male, Brostoff, Roth, Roitt, 2006)

  • 8/19/2019 Antigen Mkdu Ppds 2016

    10/32

    (Yoes Prijatna Dachlan 2010)

  • 8/19/2019 Antigen Mkdu Ppds 2016

    11/32

    (Abbas, 2010)(Yoes Prijatna Dachlan

  • 8/19/2019 Antigen Mkdu Ppds 2016

    12/32

      Peptide inding to !"# $olecules

      Involved in inding to !"# $olecules

    P1(Asp52)

    P4(Ile55)

    P6(Gln57)

    P7(Ile5)P!("er60)

    In recognition

    % T cells

    P2(#$r5%)

    P5(&e56)

    P(Asn5!)

    (Abbas, 2010)(Yoes Prijatna Dachlan

  • 8/19/2019 Antigen Mkdu Ppds 2016

    13/32

    IMMUNOGEN

    More recently, the term

     immunogen has been

     designated to refer to molecules that induce the

     activation of T or B cellsin

    the presence ofappropriate costimulatory

     molecules

    EPITOPE

    • The B and T-cellantigen

      receptors recognize a  unique region of the

      antigen

    • = Antigenic

    determinant

    • Comple Ags contain

      several epitopes(or!ynsi,R., 13 Clin %)

    (Yoes Prijatna Dachlan 2011)

    ANTIGEN are any substances that are capable, under appropriateconditions, of inducing the formation of antibodies and reactingspeci!cally "ith the antibodies so produced# They react "ith both T-cell recognition receptors and antibodies $%abris&ie,'B#, ())*+ ss Clinmm.

  • 8/19/2019 Antigen Mkdu Ppds 2016

    14/32

    Antigens/ mmunogenicity 0 Antigenicity

    Immunogenicit! is theability to induce a humoraland1or CM immune

    responses"  2 Ag 3 4-B 2 Memory B

    5

    6lasma cells 3 A#

    T 2 Ag 3 4-T 2 Memory T

      5

      $T%& T'

    Antigenicit! isthe ability to

    combinespeci!cally "iththe !nal productof the immune

    responses

    (Yoes Prijatna Dachlan 2011)

  • 8/19/2019 Antigen Mkdu Ppds 2016

    15/32

    mmunogen 0immunogenicity

    7# 6articular macromolecules of an infectious

    agent / proteins or polysaccharides(# mmunogenicity rather depends on a

    number of properties of the particularbiological system that the Ag encounters

    8# 9ature / foreignness, chemicalcompleity, accessibility, susceptibility tothe Ag processing and presentation

    :# The biological system / genotype, dosage

    0 route administration, ad;uvants

  • 8/19/2019 Antigen Mkdu Ppds 2016

    16/32

  • 8/19/2019 Antigen Mkdu Ppds 2016

    17/32

      A  Bo'ine ser+ al/+in

    !o8

    'abbit

    ot immnogenic

    trongly immnogenic

    trongly immnogenic7man

    4orei&nness

    (Yoes Prijatna Dachlan 2010)

  • 8/19/2019 Antigen Mkdu Ppds 2016

    18/32

    Molecular size

    7#The most potent immunogens aremacromolecular proteins "ithmolecular "eights ? 7)),))) @a

    (# enerally, substances "ith a M

  • 8/19/2019 Antigen Mkdu Ppds 2016

    19/32

    Mode of contact

    - An insuEcient $lo". dose of Ag 3Fo"-zone tolerance $immunologicunresponsiveness.

    - cessive doses of Ag 3 Gigh-zone

    tolerance- Boosters 3HH the clonal proliferation

    of Ag-speci!c T and B cells

    - Ioute of contact can inJuence thequalitative nature of a response$iv,id,sc,im,ip.

    (Yoes Prijatna Dachlan 2010)

  • 8/19/2019 Antigen Mkdu Ppds 2016

    20/32

    Chemical compleity

    - Gomopolymer / repeating units of a single amino acids  KLKLKL 3 6oor immunogen

    - Copolymers of ( or D even better D 8 AAs are moreimmunogenic

      KL L N LK

    - Aromatic AAs $e#g# tyrosine. contribute more toimmunogenicity than nonaromatic residues

    -  The protein organizational structure $conformational andlinear epitopes. 

    (Yoes Prijatna Dachlan 2010)

  • 8/19/2019 Antigen Mkdu Ppds 2016

    21/32

     Accessibility

      OOOAAAAA AAAAAOOO

     

     OOOAAAAA AAAAAOOO

       OOOAAAAA AAAAAOOO

     

    A-speci!c  ( and E-speci!c  antibodies antibodies

    (Yoes Prijatna Dachlan 2011)

  • 8/19/2019 Antigen Mkdu Ppds 2016

    22/32

     The protein organizationalstructure $7.

    (Yoes Prijatna Dachlan 2010)

    (5+/y, 2006)

  • 8/19/2019 Antigen Mkdu Ppds 2016

    23/32

     The protein organizationalstructure $(.

    (Yoes Prijatna Dachlan 2010)(5+/y, 2006)

  • 8/19/2019 Antigen Mkdu Ppds 2016

    24/32

    2010

    (Yoes Prijatna Dachlan 2010)

  • 8/19/2019 Antigen Mkdu Ppds 2016

    25/32

    2010

    Yoes Prijatna a!hlan 2010

  • 8/19/2019 Antigen Mkdu Ppds 2016

    26/32

    enetic constitution of the host

    -  T"o di4erent inbred strains of miceresponded very di4erently to

    synthetic polypeptide immunogen- MGC gene products play a central

    role in determining the degree to

    "hich an animal responds to animmunogen

    (Yoes Prijatna Dachlan 2010)

  • 8/19/2019 Antigen Mkdu Ppds 2016

    27/32

    A@'PQA9TR

    - Ag persistence is prolonged

    - Co-stimulatory signals are enhanced

    - Focal inJammation is increased

    -  The non-speci!c proliferation oflymphocytes is stimulated

    (Yoes Prijatna Dachlan 2010)

  • 8/19/2019 Antigen Mkdu Ppds 2016

    28/32

     The capacity of the drugs toinduce allergic reactions

    n the body, formation of hapten '  carriercon;ugates is the basis of allergic responsesto drugs such as penicillin

    6enicilloyl-protein derivative S G-C-Con;ugates 

    (Yoes Prijatna Dachlan 2010)

  • 8/19/2019 Antigen Mkdu Ppds 2016

    29/32

  • 8/19/2019 Antigen Mkdu Ppds 2016

    30/32

    5+/y, 2006

    (Yoes Prijatna Dachlan 2010)

  • 8/19/2019 Antigen Mkdu Ppds 2016

    31/32

    Ags / 6rotein, 6olysaccharide, Fipids

    T)dependent antigens

    6articularly proteinantigens,

    B cell activation occursonly

    in the presence of T-cell

    cyto&ines, and cognate

    interaction "ithactivated T

    cells

    T)independent antigens

    • 6olysaccharide molecules

      can activate B cells in the

      absence of T cell help• Type / 6neumococcal

    polysacharide, non

      mitogenic

    • Type / F6R, a cell "all  component ofn ram Dve

      bacteria, mitogenic

    (or!ynsi,R., 13 Clin %)(Yoes Prijatna Dachlan 2011)

    Abs

  • 8/19/2019 Antigen Mkdu Ppds 2016

    32/32

    poro%oite!P

    'AP

    A'P

    7epatic stage4A

    A4A

    'ing tropho%oite

      '.A

    chi%ontsP*.6P-1

    'i*ins

    .9$'

    7'P-2

    /ametocyte  P*g2:

      P*g2&0

      P*g#;